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Abstract
Background: Several disease specific instruments have been developed to identify and assess diabetes distress. In
Malaysia, the Problem Areas in Diabetes Scale has been validated in Malay, but it does not have specific domains to
assess the different areas of diabetes-related distress. Hence, we decided to use the Diabetes Distress Scale instead. To
date, only the Malay version of the Diabetes Distress Scale has been validated in Malaysia. However, English is widely
spoken by Malaysians, and is an important second language in Malaysia. Therefore, our aim was to determine the validity
and reliability of the English version of the Diabetes Distress Scale among patients with type 2 diabetes in Malaysia.
Methods: The Diabetes Distress Scale was administered to 114 patients with type 2 diabetes, who could understand
English, at baseline and 4 weeks later, at a primary care clinic in Malaysia. To assess for convergent validity, the Depression
Anxiety Stress Scale was administered at baseline. Discriminative validity was assessed by analysing the total diabetes
distress scores of participants with poor (HbA1c > 7.0%) and good glycaemic control (HbA1c≤ 7.0%).
Results: The majority of our participants were male 65(57.0%), with a median duration of diabetes of 9.5 years. Exploratory
factor analysis showed that the Diabetes Distress Scale had 4 subscales, as per the original Diabetes Distress Scale. The
overall Cronbach’s α was 0.920 (range = 0.784–0.859 for each subscale). The intraclass correlation ranged from 0.436 to 0.
643 for test-retest. The Diabetes Distress Scale subscales were significantly correlated with the different subscales of the
Depression Anxiety Stress Scale (spearman’s rho range = 0.427–0.509, p< 0.001). Patients with poor glycaemic control had
significantly higher diabetes distress score (1.88) compared to those with good glycaemic control (1.50) (p< 0.001).
Conclusions: The English version of the Diabetes Distress Scale was found to be a valid and reliable instrument to
evaluate diabetes distress among patients with type 2 diabetes in Malaysia. It can be used in clinical practice to offer a
useful indicator of the effect of diabetes-induced distress during clinic visits, especially for patients with poor glycemic
control. This would ensure that these patients are provided the care that is required.
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Background
Living with diabetes can be difficult, as it is can affect the
patient physically as well as psychologically [1, 2]. In addition
to having to take medications routinely, and having to see
their doctor regularly, patients with diabetes often need to
make several major lifestyle changes to achieve good gly-
cemic control to avoid long-term complications [3]. This
requires mental preparedness of change, self-care and discip-
line from the patient; as well as support from family, friends
and health care personnel [4]. As a consequence, patients
may sometimes feel frustrated, overwhelmed or discouraged.
These emotional burdens and worries about diabetes, and its
management, threats of complications, and unmet needs of
moral support from family, friends and health care providers
have been recognized as diabetes distress [1]. Diabetes dis-
tress is on the rise as a result of the higher global burden of
diabetes. In the United States, the prevalence of diabetes dis-
tress ranged from 21.0 to 65.5% [5–7], whilst in the
Netherlands it was 8.8% [8]. In Asia, the prevalence of
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diabetes distress was 64% in China [9], 35% in Iran [10],
48.5% in Bangladesh [11], and 11–12.5% in Malaysia [12,
13]. Significant factors related to lower diabetes distress were
older age, lower body mass index, higher self-efficacy, higher
levels of health care provider support, and a healthy diet
[14].
Although studies have shown that emotional problems
are common among patients with diabetes, diabetes dis-
tress remains largely undetected [15]. Most patients with
diabetes do not voice their emotional problems, or seek
help for the distress they experience [15]. If diabetes dis-
tress is left untreated, it may affect self-management,
and lead to poor health outcomes [16, 17]. It is therefore
important to identify patients at a primary care level
with diabetes distress, in view of its high correlation with
depression [9, 10, 18].
Several disease specific instruments have been developed
to identify and assess diabetes distress: the Diabetes Distress
Scale (DDS-17) [19], the Diabetes Health Profile (DHP-18)
[20], the Diabetes-specific Quality-of-Life Scale (DSQOLS)
[21], the Questionnaire on Stress in patients with Diabetes
(QSD) [22] and the Problem Areas in Diabetes Scale (PAID)
[23]. In Malaysia, the PAID has been validated in Malay to
assess diabetic-related emotional distress [24]. However, the
PAID does not have specific domains to assess the different
areas of diabetes-related distress, as there is only one item
that explored the patient’s view on their health care pro-
viders [19]. In addition, some items (e.g., “not having clear
and concrete goals for your diabetes care”) were difficult to
understand [19]. Hence, we decided to use the DDS-17
instead. To date, only the Malay version of the DDS-17 has
been validated in Malaysia [25]. We decided to validate the
DDS-17 in English, as English is an important second lan-
guage in Malaysia, and is widely spoken in countries which
were ex-colonies of the United Kingdom [26]. Therefore,
the aim of our study was to determine the validity and reli-
ability of the English version of the DDS-17, so that diabetes
distress can be assessed among patients who can only
understand English in Malaysia.
Methods
This validation study was conducted in a government pri-
mary care clinic, located within a tertiary hospital in Kuala
Lumpur, Malaysia, from October to November 2014.
Participants
Included were patients who had been diagnosed with type
2 diabetes for at least a year, who were on regular follow-
up, aged 18 years and above, and who were able to under-
stand English. We left it to the participants themselves to
decide whether they were comfortable in answering the
instrument in English. If they experienced any difficulty in
answering the instrument in English, then they were ex-
cluded from the study. In addition, we also excluded
patients who were pregnant or breastfeeding an infant, or
those with severe health or psychiatric/psychological prob-
lems that could cause cognitive impairments.
Sample size
Sample size was calculated based on the number of
items in the DDS-17 to participant ratio of 1:5.[27, 28]
The DDS-17 has 17 items. Hence, the minimum number
of participants required was 17*5 = 85.
Instruments used
Baseline demographic questionnaire
A baseline demographic questionnaire was used to col-
lect the demographic data of participants [such as age,
gender, occupation, education level, duration of diabetes,
presence of comorbidity, family history and diabetes
medication(s)].
The Diabetes Distress Scale (DDS-17)
The DDS-17 consists of 17 items with four subscales: emo-
tional burden (5 items), physician distress (4 items), regimen
distress (5 items) and interpersonal distress (3 items).
Response to each item was based on a 6-point Likert scale,
rated from 1 (not a problem) to 6 (a very serious problem)
concerning diabetes for the past 1 month (Additional file 1).
The total mean item score was calculated by summing up
the responses to all items and dividing by 17. The mean
score of each subscale was calculated by summing up the re-
sponses to all the items in that subscale, and dividing by the
number of items. A higher score indicates higher distress
level. A score of <2.0 was considered as “little or no distress”,
2.0–2.9 was considered as “moderate distress”, and ≥3.0 was
considered “high distress” (i.e., a level of distress worthy of
clinical attention) [5]. Permission to use the DDS-17 was ob-
tained via personal communication (dated 24 May 2014).
Face and content validity
The content validity of the DDS-17 was assessed by an
expert panel (consisting of a family physician, a researcher
who was familiar with the validation of instruments, and a
family medicine trainee). The expert panel deemed that
the DDS-17 was suitable to be used in its original form.
Hence, no changes were made to the instrument.
The DDS-17 was then piloted in five adults with Type
2 Diabetes, from a primary care clinic, to assess for face
validity. Participants were invited to read the questions,
and to evaluate verbally if the items were difficult for
them to comprehend. No further changes were made
since no problems were reported. These participants
were not included in the validation study.
The Depression Anxiety Stress Scale (DASS-21)
The Depression Anxiety Stress Scale (DASS-21) is a
generic instrument that has been used to assess the level of
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depression, anxiety and stress. It contains 21 items, and has
three subscales: depression (7 items), anxiety (7 items) and
stress (7 items), and has been validated in English in
Malaysia [29–31]. Response to each item is based on a
4-point Likert scale: 0 means “did not apply to me”, 1
means “applied to me to some degree, or some of the time”,
2 means “applied to me to a considerable degree, or a good
part of time” and 3 means “applied to me very much, or
most of the time”. For each subscale, the score of each item
was multiplied by two and summed [32]. The maximum
score of the DASS-21 is 42 [33].
Data collection
Convenience sampling was used to recruit participants, as
participants had to be screened as to whether they could an-
swer the questionnaire in English. Once these participants
were identified, the purpose of the study was explained to
them. For those who agreed to participate, written informed
consent was obtained. Participants were then asked to fill
the baseline demographic questionnaire, the DDS-17 and
the DASS-21. This took approximately 15–20 min. The re-
searcher then checked the questionnaire to ensure that all
questions were answered. Four weeks later, the DDS-17 was
mailed to each participant, with a postage-paid return enve-
lope. If a reply was not obtained within a week, participants
were contacted via the phone, and reminded to send in their
completed DDS-17 form as soon as possible. Participants
were also questioned if any significant changes or events
had occurred within the past month, and all changes were
documented. Medical records were reviewed to obtain the
latest haemoglobinA1c (HbA1c) results. Ethics approval was
obtained from the University Malaya Medical Centre
Medical Ethics Committee (approval no: 20147–394) prior
to the commencement of the study.
Data analysis
Data were analyzed using the Statistical Package for Social
Sciences 22.0 software (Chicago, Illinois, USA). Descriptive
statistics were used to describe demographic and disease
characteristics of the patients and their diabetes distress
scores. Percentages and frequencies were used for categor-
ical variables, while median and interquartile ranges were
calculated for continuous variables. Since data was not nor-
mally distributed, non-parametric tests were used.
Validity
Factor analysis
The dimensionality of the DDS-17 was analyzed using
exploratory factor analysis, using principal axis factoring
and promax oblique rotation, as the factors were correlated
[34]. An eigenvalue >1 on scree plots, indicates that there
are more than one component in the instrument [34].
Items were then screened to identify those with factor load-
ing >0.4 [35].
Convergent validity
The DASS-21 measures self-rated symptoms of depres-
sion and anxiety during the past week, and has been
used among people with diabetes [29]. Previous studies
have shown that depressive symptoms experienced by
patients with diabetes were significantly related to their
anxiety and stress [9]. Hence, the total score of the
DDS-17 was compared to the score of each subscale in
the DASS-21. Correlations were calculated using Spear-
man’s rho correlation coefficient: values <0.30 was negli-
gible, 0.30–0.49 was low, 0.50–0.69 was moderate, 0.70–
0.89 was high, and 0.90–1.00 was very high [36].
Discriminative validity
Previous literature showed that patients who had good
glycaemic control have a lower diabetes distress score
compared to those who had poor glycaemic control [25].
Hence, the Mann-Whitney U-test was used to determine
whether the DDS-17 was able to discriminate between pa-
tients with good (HbA1c ≤ 7.0%) and poor glycaemic con-




Internal consistency was assessed using Cronbach’s α
coefficient to determine whether all items in a
multi-item scale measured the same concept. This
was calculated for the entire instrument, and for
each subscale. Cronbach alpha value of <0.70 cannot
be said to have adequate internal consistency, >0.70
has adequate internal consistency [37].
The corrected item-total correlation was also per-
formed. Corrected item-total correlations were first
used to identify items which did not agree well with
other items in the questionnaire. Item-total correla-
tions should be >0.4 to be considered acceptable [38].
The effect of removing a single item on the Cron-
bach’s α was also determined.
Stability
The intra-class correlation coefficient (ICC) was used
to analyse responses obtained at test and retest. ICC
values ≥0.75 indicates excellent agreement, 0.60–0.74
shows good agreement; 0.40–0.59 indicates fair to
moderate agreement, and <0.40 indicates poor agree-
ment [39].
Results
A total of 120 diabetic patients were approached, of
which 114 agreed to participate (response rate = 95.0%)
[Fig. 1]. The demographic characteristics of participants
are shown in Table 1. There were only three participants
that were exclusively on insulin treatment.
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Construct validity
Factor analysis
Exploratory factor analysis extracted 4 factors from the
DDS-17, which explained 60% of the variation. However,
three items (items no. 7, 10 and 15) did not fit into the
4-factor model. Item 7 was allocated to the regime distress
subscale instead of the emotional burden subscale; item 10
was cross-loaded into two subscales: the emotional burden
subscale as well as the interpersonal distress subscale; whilst
item 15 had a low factor loading of 0.375 (Table 2).
Convergent validity
The total score of the DDS-17 was found to be
significantly correlated with the different subscales
in the DASS-21 (spearman’s rho range: 0.427–0.509,
p < 0.001).
Discriminative validity
Patients with poor glycaemic control had significantly
higher diabetic distress than patients with good glycaemic
control in all subscales and the total score (Table 3). The
only exception was the interpersonal distress subscale.
Reliability
The overall Cronbach’s α for the DDS-17 was 0.920,
whilst the Cronbach’s α values for the subscales
ranged from 0.784 to 0.859. All 17 items had a cor-
rected item-total correlation values of >0.4. All items
had fair to good ICC values (0.436–0.643, p < 0.001),
except for item 9 (0.382) [Table 4].
A total of 35 (30.7%) participants experienced moder-
ate to high diabetic distress. These participants were
referred to a dietitian and a counsellor.
Fig. 1 Flow of participants. DDS-17 = Diabetes Distress Scale. DASS-21 = Depression Anxiety Stress Scale
Table 1 Demographic characteristics of participants
Variables Participants (n = 114)n(%)








Presence of diabetes-related co-morbiditiesb 19 (16.7)
Positive family history of diabetes 88 (77.2)
Level of education
Primary (6 years of education) 2 (1.8)
Secondary (12 years of education) 62 (54.4)
Tertiary (at least 16 years of education) 50 (43.8)
Median duration of diabetes (years) [IQR] 9.5 [4.0–15.0]
Median HbA1c
c [IQR] 7.1 [6.4–8.5]
≤ 7.0 50 (47.2)
> 7.0 56 (52.8)
Management of diabetes
Diet control 6 (5.3)
Oral hypoglycemic agent 82 (71.9)
Insulin 3 (2.6)
Combination of oral hypoglycemic agent
and insulin
23 (20.2)
aIQR = interquartile range from the first quartile to the third quartile
bhypertension, dyslipidaemia, cardiovascular disease, stroke, diabetes-related
eye disease and diabetes-related kidney disease
cglycosylated hemoglobin, only 106 patients had documented HbA1c level
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Comparison of the diabetes distress scale in Malaysia
with other validation studies
The psychometric properties of the DDS-17 validated in
Malaysia were comparable to previous DDS-17 valid-
ation studies (Table 5).
Discussion
Our study showed that the English version of the
DDS-17 was a reliable and valid tool for assessing
diabetic distress in patients with type 2 diabetes in
Malaysia.
Table 2 Exploratory factor analysis of the English Diabetes Distress Scale-17 in Malaysia
Item no. Items Subscale Factor loadings
1 2 3 4
8 Feeling that I am often failing with my diabetes routine Regime distress 0.85
6 Feeling that I am not testing my blood sugars frequently enough 0.76
16 Not feeling motivated to keep up my diabetes self-management 0.69
12 Feeling that I am not sticking closely enough to a good meal plan 0.45
3 Not feeling confident in my day-to-day ability to manage diabetes 0.40
7a Feeling that I will end up with serious long-term complications, no
matter what I do
Emotional burden 0.69
4 Feeling angry, scared and/or depressed when I think about living
with diabetes
0.80
2 Feeling that diabetes is taking up too much of my mental and
physical energy every day
0.70
14 Feeling overwhelmed by the demands of living with diabetes 0.59
10a Feeling that diabetes controls my life 0.43 0.43
1 Feeling that my doctor doesn’t know enough about diabetes and
diabetes care
Physician distress 0.82
5 Feeling that my doctor doesn’t give me clear enough directions on
how to manage my diabetes
0.80
11 Feeling that my doctor doesn’t take my concerns seriously enough 0.71
15a Feeling that I don’t have a doctor who I can see regularly enough
about my diabetes
0.38
9 Feeling that friends or family are not supportive enough of self-care
efforts (e.g., planning activities that conflict with my schedule,
encouraging me to eat the “wrong” foods)
Interpersonal distress 0.95
17 Feeling that friends or family don’t give me the emotional support
that I would like
0.70
13 Feeling that friends or family don’t appreciate how difficult living
with diabetes can be
0.55
aItems that did not fit into the original 4-factor model










Median IQR Median IQR p-value
Total score of the DDS-17 1.50 0.76 1.88 0.87 <0.001*
DDS-17 subscales Emotional Burden 1.60 1.20 2.00 1.15 0.003*
Regime Distress 1.60 1.05 2.20 1.20 0.001*
Physician Distress 1.00 0.75 1.75 1.25 0.004*
Interpersonal Distress 1.33 1.00 1.50 1.25 0.069
HbA1c = glycosylated hemoglobin; IQR = interquartile range; *statistically significant at p < 0.05; A higher score indicates higher distress level
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Exploratory factor analysis confirmed that the English
version of the DDS-17 in Malaysia was a 4-factor model
as per the original instrument [19]. This was in contrast
to the Malay DDS-17 validation study in Malaysia,
where the authors found that their instrument was a
3-factor model: where interpersonal distress and regime
distress were merged as one factor [25]. Item 7: “Feeling
that I will end up with serious long-term complications,
no matter what I do”; was allocated to the subscale of
regime distress instead of emotional burden, which was
similar to two other studies [40, 41]. A possible explan-
ation could be participants think that having long-term
diabetes complication is a consequence of regime failure.
Item 10: “Feeling that diabetes controls my life” was
loaded into two subscales (emotional burden and inter-
personal distress). This may be because participants
perceived that diabetes affected their personal lives as
well as their relationships with others [42]. As a result, a
patient with diabetes may personally feel stressed (emo-
tional burden), and their relationship with others may
Table 4 The psychometric properties of the Diabetes Distress Scale








Cronbach’s α if item
deleted




2 0.86 0.68 0.83 2.00 2.00 2.00 2.00 0.52
4 0.76 0.81 2.00 1.00 1.00 2.00 0.61
7 0.60 0.86 2.00 1.00 2.00 2.00 0.59
10 0.62 0.84 2.00 2.00 2.00 2.00 0.62
14 0.74 0.82 2.00 1.00 2.00 2.00 0.56
Physician
Distress
1 0.78 0.62 0.71 1.00 1.00 1.00 1.00 0.44
5 0.70 0.67 1.00 1.00 1.00 1.00 0.64
11 0.59 0.73 1.00 1.00 1.00 1.00 0.52
15 0.46 0.80 1.00 1.00 2.00 2.00 0.64
Regime Distress 3 0.84 0.54 0.83 2.00 1.00 2.00 2.00 0.49
6 0.61 0.81 2.00 2.00 2.00 2.00 0.55
8 0.75 0.77 2.00 2.00 2.00 2.00 0.57
12 0.57 0.82 2.00 1.00 2.00 1.00 0.54
16 0.73 0.78 2.00 2.00 2.00 2.00 0.48
Interpersonal
Distress
9 0.81 0.67 0.72 1.00 1.00 1.00 1.00 0.38
13 0.57 0.83 1.00 1.00 1.00 2.00 0.55
17 0.73 0.64 1.00 1.00 1.00 1.00 0.44
IQR = interquartile range; *p < 0.001
Table 5 The Cronbach alpha values in previous DDS-17 validation studies
























Physician distress 0.78 0.82 0.85–0.963 0.83–0.893 0.81–0.873 0.71 0.85 0.88
Emotional burden 0.86 0.86 0.81 0.87 0.88
Regime distress 0.84 0.931b 0.78 0.821a 0.90
Interpersonal distress 0.81 0.77 0.88
Total 0.92 0.94 0.95 0.92 0.92 −2 0.90 0.93
1The regime distress and the interpersonal distress subscale were combined as the regime-and-social support-related distress subscalea / therapeutic
support distressb
2Did not report the total DDS-17 Cronbach’s α value
3Did not report Cronbach’s α values of the individual subscales
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also suffer (interpersonal distress). Item 15: “Feeling that
I don’t have a doctor who I can see regularly enough
about my diabetes”; had a low factor loading. This may
be due to the fact that our study was conducted in a
government primary clinic, where patients were not at a
liberty to select their doctor [41].
The total score of the DDS-17 had significantly mod-
erate correlation with the subscales of the DASS-21,
thus confirming the convergent validity of the DDS-17.
The diabetes distress score was significantly higher in
patients with poor compared to those with good HbA1c
values [16, 40, 43, 44], thus confirming the discrimina-
tive validity of the DDS-17.
The DDS-17 had good internal consistency which was
comparable to previous literature [19, 25, 40, 41, 43–45].
Our instrument also achieved stable reliability, and per-
formed better than the Malay DDS-17 [25]. The only
exception was item 9: “Feeling that friends or family are not
supportive enough of self-care efforts” (e.g., planning activ-
ities that conflict with my schedule, encouraging me to eat
the “wrong” foods), which had an ICC value of 0.382. This
may be because this statement may be applicable to the
participant at test, but may not be applicable at retest, as its
occurrence may be intermittent.
Findings from our study suggest that the English DDS-17
is suitable for use in daily clinical practice (in Malaysia) to
identify and assess diabetes distress, especially in patients
whose diabetes is poorly controlled. For those who have
diabetes-related emotional distress, providing necessary dia-
betes information, arranging for diabetes self-management
improvement program or problem solving therapy, or
giving encouragement, are important to alleviate diabetes
distress and improving patient outcomes (21, 40).
The strength of our study was that we validated the
English version of the DDS-17 among patients with type
2 diabetes of different ethnicity, as compared to previous
studies [25, 40, 44, 45]. Although the experience of an
illness may be universal, ethnicity and cultural differ-
ences may influence how a patient reacts to diabetes and
self-treatment; as family dynamics and the responsibil-
ities within a family may differ from one ethnic group to
another (6).
A limitation of our study was that participants were
recruited via convenience sampling, and only from one
center, so they may not be representative of the broader
population of patients with Type 2 Diabetes in Malaysia.
However, our cohort was representative of the English-
speaking patients with diabetes in Malaysia. Another
limitation was that we did not include a patient repre-
sentative in our expert panel when we performed face
and content validity. Lastly, if we had increased our sam-
ple size from 1:5 to 1:10 for the item to participant ratio,
the dimensionality of our instrument would have
performed better [46].
Conclusion
The English version of the DDS-17 was found to be a
valid and reliable instrument to assess diabetes distress
among type 2 diabetes patients in Malaysia. With the
availability of both the English and the Malay versions of
the DDS-17, these instruments can now be used in clin-
ical practice among patients who can understand English
or Malay, to offer a useful indicator of the effect of
diabetes-induced distress during clinic visits, especially
for patients with poor glycemic control. This would en-
sure that these patients are provided the care required.
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